CA
NZ
UK
AU
IND
US
Ensysce Biosciences, Inc. (NASDAQ: ENSC) is a clinical-stage pharmaceutical company developing abuse-deterrent and overdose-protected opioids using proprietary chemistry technologies. Its work targets the serious public-health problem of opioid abuse and overdose, and its lead program has received an FDA Breakthrough Therapy designation. With shares …
Beyond Air, Inc. (NASDAQ: XAIR) is a commercial-stage medical-device company built around nitric oxide therapy, most notably its LungFit platform for respiratory conditions. Unlike many penny stocks that are purely pre-revenue, Beyond Air is generating growing product revenue and has an installed base of …
EDBL penny stock analysis: Edible Garden share price, revenue growth, ready-to-drink pivot, reverse split, dilution risk and what investors should watch next.
Datavault AI Inc. (NASDAQ: DVLT) is one of the more narrative-rich names in the penny-stock universe, blending several of the market's hottest themes — artificial intelligence, data monetisation, real-world-asset tokenisation and GPU compute — into a single, fast-moving story. With shares trading below $1 …
Cosmos Health Inc. (NASDAQ: COSM) is a healthcare company that occupies an unusual position in the penny-stock landscape: it trades below $1 yet generates tens of millions of dollars in annual revenue. That combination — a micro-cap valuation on a business with real, growing …
Calidi Biotherapeutics, Inc. (NYSE American: CLDI) is a clinical-stage biotechnology company developing oncology virotherapies — engineered viruses designed to attack tumours and stimulate anti-cancer immune responses. The science targets a meaningful area of cancer research, but the company trades below $1, carries going-concern risk, …
Cango Inc. (NYSE: CANG) is a company in the midst of a dramatic transformation, pivoting from its origins as a China-based automotive-transaction services platform into a Bitcoin mining and digital-infrastructure operator. That reinvention places CANG at the intersection of two themes that draw speculative …
Nuburu, Inc. (NYSE American: BURU) began as a developer of high-power blue-laser technology and has since pivoted dramatically toward becoming an integrated defence-technology platform, pursuing acquisitions of European defence and photonics companies. The combination of a defence-sector reinvention, international acquisitions and a sub-$1 share …
Accuray Incorporated (NASDAQ: ARAY) is an established medical-device company that has slipped into penny-stock territory despite operating a substantial, revenue-generating business in radiation oncology. Unlike many sub-$1 stocks built on concepts or crypto narratives, Accuray sells sophisticated cancer-treatment systems to hospitals and clinics worldwide …
Autonomix Medical, Inc. (NASDAQ: AMIX) is a clinical-stage medical-technology company developing a catheter-based platform aimed at sensing and treating nerves, with an initial focus on relieving pain in patients with pancreatic cancer. Its technology targets a serious unmet need, and the company has reported …
Please wait processing your request...